Affilation: Tehran University of Medical Sciences, Iran (Islamic Republic of)
Journal Associated: Journal of Genetic Medicine and Gene Therapy
University of Medical Sciences in 1990. He took additional academic training at Tokyo University (Japan), Lund University and KarolinskaInstitute in Sweden. He has beenthe recipient of AvoSinaScientific award in 1999, 2002 and 2012, 2014 in Tehran. His innovation, entitled “M2000”, as a novel designed NSAID has been patented in Germany [DE 102 47 073. 1] in 2010. He serves as the Head of Department of Pathobiology in Tehran University of Medical Sciences. His research focuses on Inflammation, Immunopharmacology, Design of anti-inflammatory and immunosuppressive drugs. In particular, he is interested in immunopathogenesisand treatment of Multiple Sclerosis.